Immunotherapy combination shows benefit for patients with advanced melanoma

Novel immunotherapy boosts long-term stroke recovery in mice

New combination immunotherapy plus ART expand innate cells critical to controlling HIV

Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy